Fatma Mohamed Halfaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatma Mohamed Halfaya has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Ragab G. H.
Surgery, Anesthesiology and Radiology Department, Faculty of Veterinary Medicine, Beni Suef University, Egypt
3 shared publicationsAhmed O. M.
Physiology Division, Zoology Department, Faculty of Science, Egypt
2 shared publicationsElkheir W. A.
Department of Immunology, Military Medical Academy, Cairo, Egypt
2 shared publicationsHagag U.
Surgery, Anesthesiology and Radiology Department, Faculty of Veterinary Medicine, Beni Suef University, Egypt
2 shared publications- Ahmed Ali Farghali
Materials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Beni-Suef 62511, Egypt
1 shared publication - Emad A. Mahdi
Department of Pathology , Faculty of Veterinary Medicine Shamla St. next to the Directorate of Roads and Bridges, Beni-Suef 62511
1 shared publication
Latest Publications
- 25 October 2023
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (12) , 1-11
Anti-inflammatory and anti-oxidant activities of mesenchymal stem cells in chemically induced arthritic rats
Background Mesenchymal stem cells (MSCs) have been extensively used as cell-based treatments for decades due to their anti-inflammatory, immunomodulatory, and healing abilities. The intent of our study was to determine the efficacy of MSCs in alleviating rheumatoid arthritis (RA) induced by Complete Freund's adjuvant (CFA) and to investigate the anti-inflammatory and antioxidant characteristics of MSCs. Methods and results Intrapedally injecting 0.1 ml of CFA directly into the footpad of the right hind paw daily for 2 days was used to induce RA. Arthritic rats received four doses of MSCs (1 × 106 cells/rat/dose) intravenously through the lateral tail vein. Our results showed that arthritic rats treated with MSCs exhibited reduced levels of paw edema. Furthermore, arthritic rats treated with MSCs exhibited a significant decrease in the levels of RF, CRP, IL-1β, TNF-α, IL-17 and ADAMTS-5, along with a significant increase in the levels of IL-4 and TIMP-3. Additionally, MSCs significantly reduced the expression of TGF-β. Both the glutathione (GSH) content and antioxidant activity of GST were enhanced by MSCs, while LPO levels were suppressed. Conclusion These findings provide further evidence that MSCs are valuable in treating RA, possibly due to their anti-inflammatory and anti-oxidative properties. Thus, MSCs have potential as a more effective therapeutic strategy for treating RA.
- 25 October 2023
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (12) , 1-11
Anti-inflammatory and anti-oxidant activities of mesenchymal stem cells in chemically induced arthritic rats
Background Mesenchymal stem cells (MSCs) have been extensively used as cell-based treatments for decades due to their anti-inflammatory, immunomodulatory, and healing abilities. The intent of our study was to determine the efficacy of MSCs in alleviating rheumatoid arthritis (RA) induced by Complete Freund's adjuvant (CFA) and to investigate the anti-inflammatory and antioxidant characteristics of MSCs. Methods and results Intrapedally injecting 0.1 ml of CFA directly into the footpad of the right hind paw daily for 2 days was used to induce RA. Arthritic rats received four doses of MSCs (1 × 106 cells/rat/dose) intravenously through the lateral tail vein. Our results showed that arthritic rats treated with MSCs exhibited reduced levels of paw edema. Furthermore, arthritic rats treated with MSCs exhibited a significant decrease in the levels of RF, CRP, IL-1β, TNF-α, IL-17 and ADAMTS-5, along with a significant increase in the levels of IL-4 and TIMP-3. Additionally, MSCs significantly reduced the expression of TGF-β. Both the glutathione (GSH) content and antioxidant activity of GST were enhanced by MSCs, while LPO levels were suppressed. Conclusion These findings provide further evidence that MSCs are valuable in treating RA, possibly due to their anti-inflammatory and anti-oxidative properties. Thus, MSCs have potential as a more effective therapeutic strategy for treating RA.
- Open Access
- 18 January 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-13
Platelet-Rich Plasma Ameliorates Monosodium Iodoacetate-Induced Ankle Osteoarthritis in the Rat Model via Suppression of Inflammation and Oxidative Stress
Until now, there is no treatment that cause complete cure of the chronic inflammatory and degenerative disease, osteoarthritis (OA). Moreover, the underlying mechanisms of OA development and progress are not fully elucidated, and the present pharmacological treatment alternatives are restricted and associated with adverse side effects. Thus, the present study was conducted to evaluate the role of platelet-rich plasma (PRP) in the remedy of OA in the rat model in terms of inflammation, ankle histopathological alterations, and oxidative stress. OA was induced in male Wistar rats by injection of MIA (2mg)/50µL isotonic saline in the right ankle joint for two successive days in each rat. After the 2nd MIA injection, the osteoarthritic rats were allocated into two groups such as the MIA group (group 2) and MIA+PRP group (group 3). The MIA+PRP group was treated with PRP (50µL) by injection into the ankle joint of the right hind limb of each rat at days 14, 21, and 28 after the 2nd injection of MIA. The same equivalent volume of saline, as a substitute of PRP, was injected into the ankle joint of each rat of the normal control group (group 1) and MIA group (group 2) at the same tested periods. Swelling of joint, bodyweight, total leucocytes count (TLC), and morphological as well as histological changes of ankle joints were evaluated. Serum lipid peroxides (LPO), glutathione (GSH), and glutathione S-transferase (GST) levels were examined as biomarkers of oxidative stress. Serum tumor necrosis factor-α (TNF-α), interleukin-17 (IL-17), and interleukin-4 (IL-4) were investigated by ELISA as biomarkers of inflammation. In addition, magnetic resonance imaging (MRI) was carried out to investigate the soft tissues in joints. The obtained results revealed that PRP reduced LPO and increased GSH and GST levels in osteoarthritic rats. Also, PRP significantly diminished serum TNF-α and IL-17 levels, while it increased IL-4 serum levels in rats with MIA-induced OA. Morphological observations, histological analysis, and MRI revealed a gradual diminishing in joint inflammation and destruction of cartilage in PRP-injected osteoarthritic rats. Based on these results, it can be suggested that PRP has antiarthritic potential in MIA-induced OA, which may be mediated via suppression of inflammation and oxidative stress.
- 18 January 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-13
Open AccessPlatelet-Rich Plasma Ameliorates Monosodium Iodoacetate-Induced Ankle Osteoarthritis in the Rat Model via Suppression of Inflammation and Oxidative Stress
Until now, there is no treatment that cause complete cure of the chronic inflammatory and degenerative disease, osteoarthritis (OA). Moreover, the underlying mechanisms of OA development and progress are not fully elucidated, and the present pharmacological treatment alternatives are restricted and associated with adverse side effects. Thus, the present study was conducted to evaluate the role of platelet-rich plasma (PRP) in the remedy of OA in the rat model in terms of inflammation, ankle histopathological alterations, and oxidative stress. OA was induced in male Wistar rats by injection of MIA (2mg)/50µL isotonic saline in the right ankle joint for two successive days in each rat. After the 2nd MIA injection, the osteoarthritic rats were allocated into two groups such as the MIA group (group 2) and MIA+PRP group (group 3). The MIA+PRP group was treated with PRP (50µL) by injection into the ankle joint of the right hind limb of each rat at days 14, 21, and 28 after the 2nd injection of MIA. The same equivalent volume of saline, as a substitute of PRP, was injected into the ankle joint of each rat of the normal control group (group 1) and MIA group (group 2) at the same tested periods. Swelling of joint, bodyweight, total leucocytes count (TLC), and morphological as well as histological changes of ankle joints were evaluated. Serum lipid peroxides (LPO), glutathione (GSH), and glutathione S-transferase (GST) levels were examined as biomarkers of oxidative stress. Serum tumor necrosis factor-α (TNF-α), interleukin-17 (IL-17), and interleukin-4 (IL-4) were investigated by ELISA as biomarkers of inflammation. In addition, magnetic resonance imaging (MRI) was carried out to investigate the soft tissues in joints. The obtained results revealed that PRP reduced LPO and increased GSH and GST levels in osteoarthritic rats. Also, PRP significantly diminished serum TNF-α and IL-17 levels, while it increased IL-4 serum levels in rats with MIA-induced OA. Morphological observations, histological analysis, and MRI revealed a gradual diminishing in joint inflammation and destruction of cartilage in PRP-injected osteoarthritic rats. Based on these results, it can be suggested that PRP has antiarthritic potential in MIA-induced OA, which may be mediated via suppression of inflammation and oxidative stress.
- 2 September 2020
- Published by Egyptian Knowledge Bank in Journal of Veterinary Medical Research
Efficacy of Hyaluronic Acid in the Treatment of MIA-induced Ankle Osteoarthritis in Rats and its Effect on Antioxidant Response Element
Ankle osteoarthritis (OA) is a long-standing inflammatory degeneration disease; until now, its pathogenesis remains ambiguous. There is no complete remedy from OA and the present pharmacological therapy choices are restrained and combined with undesirable side effects. Clinically, Hyaluronic acid (HA) is widely consumed to cure OA. The present experiment aimed to assess the role of HA in the remedy of experimentally Monosodium iodoacetate (MIA) -induced ankle OA in the rat model. Thirty male Wistar rats were divided into 3 groups (each of 10 rats). Rats of group I were injected with 1 mg MIA in the right ankle joint for two successive days, while those of group II were treated with saline instead of MIA; and group III (osteoarthritic + HA) rats were injected with HA in the ankle joint at 2nd, 3rd, and 4th weeks following injection of MIA. Bodyweight, ankle measurement, total leukocytescount (TLC), antioxidant response element (ARE) level, and joint Magnetic Resonance Imaging (MRI) were investigated. HA reduced expressions of joint ARE level. HA also markedly reduced the TLC. The administration of HA decreases ankle measurement in MIA-induced OA rats. MRI of HA showed a gradual reduction in joint damage. These results suggest that HA has improvement effects on OA rats which are assessed through anti-inflammatory and antioxidant effects.
- 2 September 2020
- Published by Egyptian Knowledge Bank in Journal of Veterinary Medical Research
Efficacy of Hyaluronic Acid in the Treatment of MIA-induced Ankle Osteoarthritis in Rats and its Effect on Antioxidant Response Element
Ankle osteoarthritis (OA) is a long-standing inflammatory degeneration disease; until now, its pathogenesis remains ambiguous. There is no complete remedy from OA and the present pharmacological therapy choices are restrained and combined with undesirable side effects. Clinically, Hyaluronic acid (HA) is widely consumed to cure OA. The present experiment aimed to assess the role of HA in the remedy of experimentally Monosodium iodoacetate (MIA) -induced ankle OA in the rat model. Thirty male Wistar rats were divided into 3 groups (each of 10 rats). Rats of group I were injected with 1 mg MIA in the right ankle joint for two successive days, while those of group II were treated with saline instead of MIA; and group III (osteoarthritic + HA) rats were injected with HA in the ankle joint at 2nd, 3rd, and 4th weeks following injection of MIA. Bodyweight, ankle measurement, total leukocytescount (TLC), antioxidant response element (ARE) level, and joint Magnetic Resonance Imaging (MRI) were investigated. HA reduced expressions of joint ARE level. HA also markedly reduced the TLC. The administration of HA decreases ankle measurement in MIA-induced OA rats. MRI of HA showed a gradual reduction in joint damage. These results suggest that HA has improvement effects on OA rats which are assessed through anti-inflammatory and antioxidant effects.
- 2 September 2020
- Published by Egyptian Knowledge Bank in Journal of Veterinary Medical Research
Effect of Platelet-Rich Plasma on MMP-13, ARE and TGF β1 in MIA-induced Osteoarthritis in Rats
Ankle osteoarthritis (OA) is an inflammatory deterioration chronic disease; yet, OA pathogenesis is obscure. There is no absolute cure from OA and the present pharmacological medication options are constrained and associated with adverse aspect effects. Clinically, Platelet-rich plasma (PRP) is usually used to cure OA. The present study was designed to evaluate the role of PRP in the treatment of experimentally Monosodium iodoacetate (MIA)-induced ankle osteoarthritis in the rat model. Thirty male Wistar rats were divided into three groups (each of 10 rats). Rats of group I were injected with 1 mg MIA in the right ankle joint for two consecutive days, while those of group II were treated with saline instead of MIA; and group III( osteoarthritic +PRP) rats were injected with PRP in the ankle joint at 14, 21, and 28 days after MIA injection. Paw oedema, scoring of arthritis,Matrix metalloproteinase 13 (MMP13) level, antioxidant response element(ARE) level, and joint transforming growth factor beta1 (TGF β 1) were evaluated. PRP reduces expression of joint, MMP13, ARE level, and TGF β 1. PRP also significantly reduces the score of arthritis. The administration of PRP decreases paw oedema in MIA-induced OA rats. These results suggest that PRP has marked effect against OA in MIA-induced osteoarthritic rats which are mediated through the anti-inflammatory and antioxidant effects.
- 2 September 2020
- Published by Egyptian Knowledge Bank in Journal of Veterinary Medical Research
Effect of Platelet-Rich Plasma on MMP-13, ARE and TGF β1 in MIA-induced Osteoarthritis in Rats
Ankle osteoarthritis (OA) is an inflammatory deterioration chronic disease; yet, OA pathogenesis is obscure. There is no absolute cure from OA and the present pharmacological medication options are constrained and associated with adverse aspect effects. Clinically, Platelet-rich plasma (PRP) is usually used to cure OA. The present study was designed to evaluate the role of PRP in the treatment of experimentally Monosodium iodoacetate (MIA)-induced ankle osteoarthritis in the rat model. Thirty male Wistar rats were divided into three groups (each of 10 rats). Rats of group I were injected with 1 mg MIA in the right ankle joint for two consecutive days, while those of group II were treated with saline instead of MIA; and group III( osteoarthritic +PRP) rats were injected with PRP in the ankle joint at 14, 21, and 28 days after MIA injection. Paw oedema, scoring of arthritis,Matrix metalloproteinase 13 (MMP13) level, antioxidant response element(ARE) level, and joint transforming growth factor beta1 (TGF β 1) were evaluated. PRP reduces expression of joint, MMP13, ARE level, and TGF β 1. PRP also significantly reduces the score of arthritis. The administration of PRP decreases paw oedema in MIA-induced OA rats. These results suggest that PRP has marked effect against OA in MIA-induced osteoarthritic rats which are mediated through the anti-inflammatory and antioxidant effects.
- Open Access
- 1 December 2017
- Published by Egyptian Knowledge Bank in Journal of Veterinary Medical Research
- Vol. 24 (2) , 247-256
Comparison of quality of anesthetic effect between intramuscularly administered ketamine, intravenously administered ketamine and intravenously administered propofol in diazepam premedicated goats
This study aimed to evaluate intramuscularly administered ketamine,intravenously administered ketamine and intravenously administered propofol indiazepam premedicated goats. Nine native female goats divided into three groups(each of 3 goats) were premedicated with diazepam 1 mg/kg intramuscularly. Goatsof group I were treated with ketamine (8 mg/kg) intravenously, while those of groupII treated with ketamine (10 mg/kg) intramuscularly, and group III injected withpropofol (5 mg/kg) intravenously. The mean anesthetic onset, anesthetic duration,and total recovery period were calculated. The mean heart rate (HR), respiratoryrate (RR), rectal temperature (RT) and biochemical parameters also were recorded.Satisfactory anesthesia and immobilization (smooth induction, and smoothrecovery) needed for surgical interventions of short duration were achieved in allgroups. The induction was good and smooth in groups I and III. The quality ofrecovery was good in groups III and I and recovery is longer in group II. Inconclusion, this study indicates that the 3 regimens are associated with acceptableanesthetic characteristics; Propofol IV is superior to ketamine because it providesuneventful onset and recovery which are more rapid than ketamine IV or ketamineIM, so reduces anaesthetic risk while administration of ketamine intravenously issuperior to its administration intramuscularly.
- 1 December 2017
- Published by Egyptian Knowledge Bank in Journal of Veterinary Medical Research
- Vol. 24 (2) , 247-256
Open AccessComparison of quality of anesthetic effect between intramuscularly administered ketamine, intravenously administered ketamine and intravenously administered propofol in diazepam premedicated goats
This study aimed to evaluate intramuscularly administered ketamine,intravenously administered ketamine and intravenously administered propofol indiazepam premedicated goats. Nine native female goats divided into three groups(each of 3 goats) were premedicated with diazepam 1 mg/kg intramuscularly. Goatsof group I were treated with ketamine (8 mg/kg) intravenously, while those of groupII treated with ketamine (10 mg/kg) intramuscularly, and group III injected withpropofol (5 mg/kg) intravenously. The mean anesthetic onset, anesthetic duration,and total recovery period were calculated. The mean heart rate (HR), respiratoryrate (RR), rectal temperature (RT) and biochemical parameters also were recorded.Satisfactory anesthesia and immobilization (smooth induction, and smoothrecovery) needed for surgical interventions of short duration were achieved in allgroups. The induction was good and smooth in groups I and III. The quality ofrecovery was good in groups III and I and recovery is longer in group II. Inconclusion, this study indicates that the 3 regimens are associated with acceptableanesthetic characteristics; Propofol IV is superior to ketamine because it providesuneventful onset and recovery which are more rapid than ketamine IV or ketamineIM, so reduces anaesthetic risk while administration of ketamine intravenously issuperior to its administration intramuscularly.